The effect of GLP-1R agonists liraglutide and exendin-4 was examined in vitro on LOVO, CA-77, MCF-7, MDA-MB-231, KPL-1, MB-468, 4TI, BT483, ZR751, LNCap, PC3, ALVA-41, DU145, LNCap, PANC-1, MiaPaCa-2, PANC, CT26, SKOV3, OVCAR3, OVCAR4, A2780, and ES-2 cell lines that are expressed in several cancers including colorectal, pancreatic, thyroid, breast, prostate, ovarian, and colon (Table 1)
Patients carrying specific GLP1R variants may exhibit heightened receptor sensitivity, increasing both the likelihood of GI side effects and the potential for symptom improvement
Medication arrives in cold-chain packaging with all injection supplies included
In Part 5 of my LEAN GAINS SERIES, I break down the most common building phase mistakes that accelerate fat gain and limit muscle growth
Competition in the GLP-1 sector is never about elimination, but about leveraging respective strengths to advance the development of metabolic disease treatments
S., Lindsay, J